Yolanda Meije1, Benito Almirante1, José Luis Del Pozo2, María Teresa Martín3, Nuria Fernández-Hidalgo1, Adriana Shan4, Jana Basas1, Albert Pahissa1, Joan Gavaldà5. 1. Infectious Diseases Research Laboratory, Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain. 2. Infectious Disease Division, Internal Medicine Department, Clínica Universitaria de Navarra, Navarra, Spain. 3. Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain. 4. Microbiology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. 5. Infectious Diseases Research Laboratory, Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Electronic address: joan.gavalda@vhir.org.
Abstract
BACKGROUND: The effectiveness of daptomycin versus vancomycin for treating experimental methicillin-susceptible (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) catheter-related infection by antibiotic-lock technique was assessed. METHODS: One MSSA strain and one clinical MRSA isolate were used. A preliminary in vitro study determined the minimum biofilm eradication concentration (MBEC) of vancomycin and daptomycin. An intravenous catheter was implanted in New Zealand white rabbits. Infection was induced by 24 h locking the catheter with 0.3 mL of broth culture containing MSSA or MRSA. The 24 h of antibiotic-lock treatment groups were: control, vancomycin 10 mg/mL, daptomycin 5 mg/mL and daptomycin 50 mg/mL. RESULTS: Daptomycin showed greater in vitro activity than vancomycin against biofilm bacteria (MBECs of vancomycin and daptomycin for MSSA, >2000 mg/L and 7 mg/L; MRSA, >2000 mg/L and 15 mg/L). Daptomycin 5 mg/mL achieved significant reductions relative to vancomycin 10 mg/mL in log10 cfu recovered from catheter tips for both strains (P < 0.05). Only daptomycin 50 mg/mL achieved negative catheter tip cultures (up to 75% in MSSA and 85% in MRSA, P < 0.05), showing the greatest median log10 cfu reduction compared to controls (6.07 in MSSA and 6.59 in MRSA, P < 0.05). CONCLUSIONS: Daptomycin 50 mg/mL showed the highest activity against both strains biofilms.
BACKGROUND: The effectiveness of daptomycin versus vancomycin for treating experimental methicillin-susceptible (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) catheter-related infection by antibiotic-lock technique was assessed. METHODS: One MSSA strain and one clinical MRSA isolate were used. A preliminary in vitro study determined the minimum biofilm eradication concentration (MBEC) of vancomycin and daptomycin. An intravenous catheter was implanted in New Zealand white rabbits. Infection was induced by 24 h locking the catheter with 0.3 mL of broth culture containing MSSA or MRSA. The 24 h of antibiotic-lock treatment groups were: control, vancomycin 10 mg/mL, daptomycin 5 mg/mL and daptomycin 50 mg/mL. RESULTS:Daptomycin showed greater in vitro activity than vancomycin against biofilm bacteria (MBECs of vancomycin and daptomycin for MSSA, >2000 mg/L and 7 mg/L; MRSA, >2000 mg/L and 15 mg/L). Daptomycin 5 mg/mL achieved significant reductions relative to vancomycin 10 mg/mL in log10 cfu recovered from catheter tips for both strains (P < 0.05). Only daptomycin 50 mg/mL achieved negative catheter tip cultures (up to 75% in MSSA and 85% in MRSA, P < 0.05), showing the greatest median log10 cfu reduction compared to controls (6.07 in MSSA and 6.59 in MRSA, P < 0.05). CONCLUSIONS:Daptomycin 50 mg/mL showed the highest activity against both strains biofilms.
Authors: Raymond Schuch; Babar K Khan; Assaf Raz; Jimmy A Rotolo; Michael Wittekind Journal: Antimicrob Agents Chemother Date: 2017-06-27 Impact factor: 5.191
Authors: Benito Almirante; Joan Gavaldà; Jana Basas; Marta Palau; Carlos Ratia; José L Del Pozo; María Teresa Martín-Gómez; Xavier Gomis; Eduard Torrents Journal: Antimicrob Agents Chemother Date: 2018-01-25 Impact factor: 5.191
Authors: Sonia Pasquaroli; Barbara Citterio; Andrea Di Cesare; Mehdi Amiri; Anita Manti; Claudia Vuotto; Francesca Biavasco Journal: Pathogens Date: 2014-09-18
Authors: Blanca Humanes; Juan Carlos Jado; Sonia Camaño; Virginia López-Parra; Ana María Torres; Luís Antonio Álvarez-Sala; Emilia Cercenado; Alberto Tejedor; Alberto Lázaro Journal: Biomed Res Int Date: 2015-10-04 Impact factor: 3.411